About Walter Narajowski
Walter Narajowski is a director of Nuclein and a partner at LabDx, a biotech consulting company, where he has worked since 2015. He was chief operating officer of Minute Molecular Diagnostics from November 2020 until it merged with Nuclein in 2023.
Earlier he was senior vice president and general manager of Roka BioScience from 2009 to 2015 and a board member of MDxHealth from 2014 to 2019. He was president and chief executive officer of Pathway Diagnostics, which Quest Diagnostics bought in 2008, and a vice president and general manager at Focus Diagnostics. He spent more than 20 years at Abbott Laboratories. He has a master's degree in bioengineering from the University of Utah and a bachelor's degree in electrical engineering from the Illinois Institute of Technology.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Walter Narajowski in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Walter Narajowski works with at each company, as listed on that company's latest Form D.
